Jazz Pharmaceuticals Raises $1 Billion Through Senior Notes and Share Buybacks

Jazz Pharmaceuticals has launched a private offering of $1 billion in exchangeable senior notes maturing in 2032, alongside a concurrent program to repurchase company shares.